Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, has announced the merger of its portfolio companies, Vector Laboratories and Absolute Biotech. The strategic move aims to advance the combined platform’s position as a comprehensive supplier of both custom-engineered and catalog antibodies and sophisticated bioconjugation linkers and as a leader in providing deep bioconjugation expertise. Vector Laboratories is a manufacturer of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical stage biotherapeutics. Absolute Biotech is a global manufacturer and supplier, serving customers with antibody reagents, kits, and services to support annotation, validation, sequencing, engineering, and recombinant antibody manufacturing.
Read the full article: TSCP Portfolio Companies Vector Laboratories and Absolute Biotech Announce Merger, Strengthening Support for Life Science Customers //
Source: https://www.businesswire.com/news/home/20240611485629/en/TSCP-Portfolio-Companies-Vector-Laboratories-and-Absolute-Biotech-Announce-Merger-Strengthening-Support-for-Life-Science-Customers